Trevi Therapeutics (TRVI) Q1 2025 Earnings

18MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.13
-0.12
-0.1
-0.09

Details

Expected EPS
-0.128182
Actual EPS
-0.11
Surprise EPS
0.02
Surprise Percent
+14.18%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.11 per share for Q1 2025.

0 Comments

Share your thoughts